The impact of multi-institutional collaborations and partnerships led the discussion among Arizona’s Bioscience Roadmap Steering Committee members during its gathering earlier today.
These collaborations have been a strength for Arizona—between our hospitals, research institutes, universities, companies, economic development organizations, and more. One of the most instrumental collaborations in Arizona’s bioscience growth and progress is the Arizona Alzheimer’s Consortium—the nation’s leading model of statewide collaboration in Alzheimer’s disease research.
Drs. Eric Reiman and Richard Caselli, members of the Alzheimer’s consortium and Flinn Foundation Board of Directors, led a presentation followed by an engaging discussion with moderator Jennifer Barton and panelists Jani Ingram, Mark Van Dyke, Kathleen Lee, and David Spetzler about their ongoing collaborations.